ESR1 and neoplasm: Albert et al. developed a nomogram that can be used to estimate mastectomy-free survival and predict the benefit of radiation for patients treated with breast conserving surgery (BCS) based on age, race, tumor size, estrogen receptor (ER) status, RT, and nodal pathology [10].